Skip to main content
    A

    Ascendis Pharma AS (ASND)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $271.19
    -0.54 (-0.20%)

    Market Cap: $18.06B

    Last updated: Nov 17, 2026 at 4:23 PM ET

    Ascendis Pharma AS (ASND) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Ascendis Pharma AS (ASND) has a latest price of $271.19 on Nov 17, 2026, 3.9% below its 52-week high of $282.15. Its price rose 32.7% over the past 12 months. The month-end price rose 1,190.5% over the 10 years through Oct 2026, a compound annual rate of 29.1%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $266.72 in Jun 2026 and its lowest $19.47 in Oct 2016, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart ASND with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ASND.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 4.5%, and over 6 months it rose 14.0%. The month-end price rose 181.3% over the 3 years through Oct 2026, a compound annual rate of 41.2%.

    PeriodChange
    1 month+17.9%
    3 months+4.5%
    6 months+14.0%
    12 months+32.7%
    12 months, with dividends+32.7%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+181.3%+41.2%
    5 years+65.7%+10.6%
    10 years+1,190.5%+29.1%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2019, when the price rose 122.1%, and its weakest was 2021, when it fell 19.3%.

    YearCloseChange
    2026 through Oct 2026$251.27+17.8%
    2025$213.24+54.9%
    2024$137.67+9.3%
    2023$125.95+3.1%
    2022$122.13-9.2%
    2021$134.53-19.3%
    2020$166.78+19.9%
    2019$139.12+122.1%
    2018$62.65+56.4%
    2017$40.06+97.9%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 11.7% above its 50-day average of $242.71 and 12.8% above its 200-day average of $240.32.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$271.19
    52-week high$282.15-3.9%
    52-week low$188.08+44.2%
    50-day average$242.71+11.7%
    200-day average$240.32+12.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 29.2%.

    MeasureValue
    1-year beta0.44
    Largest fall, 1 year-19.7%
    Largest fall, 3 years-29.2%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About ASND

    What is ASND's 1-year price change?

    Ascendis Pharma AS's price rose 32.7% over the past 12 months. With dividends included, the 12-month total return was 32.7%.

    What is ASND's 5-year price change?

    Ascendis Pharma AS's month-end price rose 65.7% over the 5 years through Oct 2026, a compound annual rate of 10.6%. These figures leave out dividends.

    What is ASND's 52-week high and low?

    Ascendis Pharma AS's 52-week high is $282.15 and its 52-week low is $188.08. Its latest price of $271.19 on Nov 17, 2026 is 3.9% below the high.

    What is ASND's beta?

    Ascendis Pharma AS's 1-year beta against the S&P 500 is 0.44, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 19.7%.

    Is the ASND chart free?

    Yes. Advanced Charting for ASND is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.